Literature DB >> 17880865

Early intervention in schizophrenia: current and future perspectives.

Matcheri S Keshavan1, Ali Amirsadri.   

Abstract

The last decade has witnessed an expanding interest in the concept of early intervention (EI) in psychotic disorders, notably schizophrenia. This is supported by the well-established association between prolonged untreated illness duration and poor outcome, as well as some evidence of progressive neurobiological changes in the early course of schizophrenia, both in the prepsychotic and psychotic phases as evidenced by brain imaging studies in schizophrenia. Increasingly, mental health service systems around the world have been incorporating specialized EI programs. Controlled effectiveness studies in recent years have yielded encouraging data. Several questions in regard to the timing, choice of interventions, and the populations most likely to benefit from EIs still remain. More evidence-based data are needed to place the EI models in schizophrenia on firm footing in order to effectively implement them in the resource-strapped community mental health service settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880865     DOI: 10.1007/s11920-007-0040-8

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  23 in total

Review 1.  Treatment of the schizophrenia prodrome: is it presently ethical?

Authors:  B A Cornblatt; T Lencz; J M Kane
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

2.  Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia.

Authors:  P M Thompson; C Vidal; J N Giedd; P Gochman; J Blumenthal; R Nicolson; A W Toga; J L Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

3.  Commentary: Service system perspectives on early intervention research.

Authors:  Crystal R Blyler
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

Review 4.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 5.  Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions.

Authors:  Patrick D McGorry; Ian B Hickie; Alison R Yung; Christos Pantelis; Henry J Jackson
Journal:  Aust N Z J Psychiatry       Date:  2006-08       Impact factor: 5.744

6.  Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia.

Authors:  Ralf Pukrop; Frauke Schultze-Lutter; Stephan Ruhrmann; Anke Brockhaus-Dumke; Indira Tendolkar; Andreas Bechdolf; Eveline Matuschek; Joachim Klosterkötter
Journal:  J Clin Exp Neuropsychol       Date:  2006-11       Impact factor: 2.475

7.  Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications.

Authors:  D Linszen; P Dingemans; M Lenior
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

8.  A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness.

Authors:  Lone Petersen; Pia Jeppesen; Anne Thorup; Maj-Britt Abel; Johan Øhlenschlaeger; Torben Østergaard Christensen; Gertrud Krarup; Per Jørgensen; Merete Nordentoft
Journal:  BMJ       Date:  2005-09-02

Review 9.  Neuroleptics and the natural course of schizophrenia.

Authors:  R J Wyatt
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

10.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Shona Francey; Elizabeth M Cosgrave; Dominic Germano; Jenny Bravin; Tony McDonald; Alison Blair; Stephen Adlard; Henry Jackson
Journal:  Arch Gen Psychiatry       Date:  2002-10
View more
  7 in total

Review 1.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

2.  Disclosure of psychiatric manifestations of 22q11.2 deletion syndrome in medical genetics: A 12-year retrospective chart review.

Authors:  Serena Talcott Baughman; Emily Morris; Kimberly Jensen; Jehannine Austin
Journal:  Am J Med Genet A       Date:  2015-05-31       Impact factor: 2.802

3.  Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability.

Authors:  Wagner F Gattaz; Ricardo Saracco-Alvarez; Claudiane Salles Daltio; Martinus T Van de Bilt; Jose Julian Ortegón; Sergio J Villaseñor-Bayardo; Mario Louzã; Helio Elkis; Bernardo Soares; Patricia Cabrera Jaramillo; Fabio Lawson; Leonardo Díaz-Galvis
Journal:  Neuropsychiatr Dis Treat       Date:  2020-09-10       Impact factor: 2.570

4.  Formal thought disorder and the autism spectrum: relationship with symptoms, executive control, and anxiety.

Authors:  Marjorie Solomon; Sally Ozonoff; Cameron Carter; Rochelle Caplan
Journal:  J Autism Dev Disord       Date:  2008-02-23

Review 5.  Staging in neuropsychiatry: a heuristic model for understanding, prevention and treatment.

Authors:  Patrick D McGorry
Journal:  Neurotox Res       Date:  2010-04-03       Impact factor: 3.911

6.  Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia.

Authors:  Jennifer Kern Sliwa; Cynthia A Bossie; Dong-Jing Fu; Ibrahim Turkoz; Larry Alphs
Journal:  Neuropsychiatr Dis Treat       Date:  2012-08-27       Impact factor: 2.570

7.  Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? results of a retrospective study.

Authors:  Diego Primavera; Chiara Bandecchi; Tiziana Lepori; Lucia Sanna; Eraldo Nicotra; Bernardo Carpiniello
Journal:  Ann Gen Psychiatry       Date:  2012-08-02       Impact factor: 3.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.